Product Uses
Novox is a non-steroidal anti-inflammatory drug (NSAID) indicated for the relief of pain and inflammation associated with osteoarthritis in dogs.
Product Contains
carprofen
Dosage and Administration
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. Novox Caplets are scored and the dosage should be worked out to the nearest half-tablet. Novox Caplets may be given with or without food, but ensure that the dog consumes the complete dose for the full benefit.
Warnings, Side Effects and Drug Interactions
Novox Caplets should not be used in dogs exhibiting previous hypersensitivity to carprofen. As a class, NSAIDs can be associated with kidney and gastrointestinal toxicity. The most commonly reported reactions with carprofen are vomiting and diarrhea, occasionally bloody. Additional adverse reactions involving the kidneys, blood, brain, skin and liver have also been seen. The effects of damage to these organs commonly include: decreased appetite, increased water consumption, increased urination, anemia, jaundice, lethargy, incoordination, seizures, or behavioral changes. In rare situations, death has been reported. Approximately one quarter of the reports of liver damage associated with carprofen have been in Labrador Retrievers.
Patients at greatest risk for kidney toxicity are those that are dehydrated, on concomitant diuretic therapy, or those with pre-existing kidney, heart or liver problems. Novox should not be given with any drugs which could exacerbate toxicity, such as corticosteroids or other NSAIDs or any drugs known to be toxic to kidneys. Novox is not recommended for use in dogs with bleeding disorders. The safety of Novox in dogs less than 6 weeks of age, in pregnant or lactating animals or those used for breeding has not been established. Care should be taken if administering with other drugs which are highly protein bound or metabolized through the liver, as this may increase the availability of the drug and cause adverse effects.
Should any adverse effects be noted during treatment, Novox should be discontinued and a veterinarian contacted for assistance.
This product is not for use in cats.
Storage
Store tablets at controlled room temperature 15°-30°C (59°-86°F).
Manufacturer
Vedco, Inc.
Registration Status
ANADA #200-366, Approved by FDA
Federal law restricts this drug to use by or on the order of a licensed veterinarian.